EBW-53621-13342
3 vaccinations
11 coded responses
34 check-ins
11 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 951 / CA
- Registered
- 2021-03-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-30
Registered in v-safe
-
2021-03-30
Dose 1 — Pfizer-BioNTech
- 2021-03-30
- 2021-03-31
- 2021-04-01
-
2021-04-02
Survey response — days 1–6 daily, dose 1MedDRA: Insomnia — Feeling: GoodFree text: Insomnia, but might have been caused by relatively late coffee as wellMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-08
-
2021-04-13
Survey response — day 14, dose 1MedDRA: Arthralgia, Back pain — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Muscle ache in the back and shoulder areaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-20
-
2021-04-27
Dose 2 — Pfizer-BioNTech
-
2021-04-27
Survey response — day 0, dose 2MedDRA: Paranasal sinus discomfort — Feeling: Fair · Chills, Headache, Muscle or body aches, Fatigue or tirednessFree text: Nasal pressureMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-28
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal painFree text: Swollen lymph nodes on the neckMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-29
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Muscle or body aches, Abdominal painAdult check-in
- 2021-04-30
- 2021-05-01
- 2021-05-04
- 2021-05-11
- 2021-05-20
- 2021-06-01
-
2021-06-08
Survey response — day 42, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: swollen lymph nodes in the neckMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-27
Survey response — 3 months, dose 2MedDRA: Headache — Feeling: GoodFree text: HeadachesMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-10-28
Dose 3 — Pfizer-BioNTech
- 2021-10-28
- 2021-10-28
-
2021-10-29
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Joint pains, Muscle or body achesAdult check-in
-
2021-10-30
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Muscle or body achesAdult check-in
-
2021-10-31
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
-
2021-11-01
Survey response — days 1–6 daily, dose 3MedDRA: Chest pain — Feeling: Good · Site: Pain · Muscle or body achesFree text: a dull ache in the heart areaMedDRA releases: 2024-11 · check-in free text available
- 2021-11-02
-
2021-11-13
Survey response — day 14, dose 3MedDRA: Dizziness, Head discomfort, Nasal congestion — Feeling: FairFree text: Stuffier nose, dizziness, pressure in the forehead areaMedDRA releases: 2024-11 · check-in free text available
- 2021-11-18
- 2021-12-02
-
2021-12-10
Survey response — day 42, dose 3MedDRA: Eczema — Feeling: GoodFree text: Skin condition emerged, probably eczemaMedDRA releases: 2024-11 · check-in free text available
-
2022-01-27
Survey response — 3 months, dose 3MedDRA: COVID-19, Chest pain, Cough, Fatigue, Headache, Myalgia, Nasal congestion, Oropharyngeal pain, Pyrexia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Covid-19 infection with cough, chest pain, fever, headache, soar throat, muscle aches, fatigue and stuffy noseMedDRA releases: 2024-11 · check-in free text available
-
2022-01-27
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-03-31
Call successfulParticipant prefers to complete VAERS report online
-
2022-10-30
Survey response — 12 months, dose 3MedDRA: Back pain, Menstruation irregular, Respiratory tract infection — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Respiratory infection. Backache. Irregular periodsMedDRA releases: 2024-11 · check-in free text available
-
2022-10-30
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-10-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-30 | Pfizer-BioNTech | |
| 2 | 2021-04-27 | Pfizer-BioNTech | |
| 3 | 2021-10-28 | Pfizer-BioNTech | No |
Call center
2 call center cases
1 successful · 1 unsuccessful
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Insomnia, but might have been caused by relatively late coffee as well
Release 7 — day 14, dose 1
Symptoms: Muscle ache in the back and shoulder area
Release 8 — day 0, dose 2
Systemic reaction (other): Nasal pressure
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Swollen lymph nodes on the neck
Release 8 — day 42, dose 2
Symptoms: swollen lymph nodes in the neck
Release 9 — 3 months, dose 2
Symptoms: Headaches
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): a dull ache in the heart area
Release 10 — day 14, dose 3
Symptoms: Stuffier nose, dizziness, pressure in the forehead area
Release 10 — day 42, dose 3
Symptoms: Skin condition emerged, probably eczema
Release 11 — 3 months, dose 3
Symptoms: Covid-19 infection with cough, chest pain, fever, headache, soar throat, muscle aches, fatigue and stuffy nose
Release 12 — 12 months, dose 3
Symptoms: Respiratory infection. Backache. Irregular periods
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Back pain | ✓ | ✓ | ✓ |
| SD | Chest pain | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Eczema | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Head discomfort | · | · | ✓ |
| SD | Headache | ✓ | · | ✓ |
| SD | Lymphadenopathy | ✓ | ✓ | ✓ |
| SD | Menstruation irregular | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract infection | · | · | ✓ |
| SRO | Chest pain | · | · | ✓ |
| SRO | Insomnia | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Paranasal sinus discomfort | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release